 | Up a level |
Asif, M., Kaygusuz, E., Shinawi, M., Nickelsen, A., Hochscherf, J., Lindenblatt, D., Noegel, A. A., Tinschert, S., Niefind, K., Fortugno, P., Jose, J., Brancati, F., Nuernberg, P. and Hussain, M. S. (2020). De novo pathogenic variants in CSNK2B cause a new intellectual disability-craniodigital syndrome distinguished from Poirier-Bienvenu neurodevelopmental syndrome. Eur. J. Hum. Genet., 28 (SUPPL 1). S. 129 - 131. LONDON: SPRINGERNATURE. ISSN 1476-5438
Chojnacki, K., Lindenblatt, D., Winska, P., Wielechowska, M., Toelzer, C., Niefind, K. and Bretner, M. (2021). Synthesis, biological properties and structural study of new halogenated azolo [4,5-b]pyridines as inhibitors of CK2 kinase. Bioorganic Chem., 106. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE. ISSN 1090-2120
Chojnacki, K., Winska, P., Wielechowska, M., Lukowska-Chojnacka, E., Toelzer, C., Niefind, K. and Bretner, M. (2018). Biological properties and structural study of new aminoalkyl derivatives of benzimidazole and benzotriazole, dual inhibitors of CK2 and PIM1 kinases. Bioorganic Chem., 80. S. 266 - 276. SAN DIEGO: ACADEMIC PRESS INC ELSEVIER SCIENCE. ISSN 1090-2120
Swider, R., Maslyk, M., Zapico, J. M., Coderch, C., Panchuk, R., Skorokhyd, N., Schnitzler, A., Niefind, K., de Pascual-Teresa, B. and Ramos, A. (2015). Synthesis, biological activity and structural study of new benzotriazole-based protein kinase CK2 inhibitors. RSC Adv., 5 (89). S. 72482 - 72495. CAMBRIDGE: ROYAL SOC CHEMISTRY. ISSN 2046-2069